drugset / Trial / NCT00660374

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

NCT00660374

Phase 2 Completed 402 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in South America. This trial aims for a comparison of the safety and efficacy of insulin NPH and a new insulin formulation on blood glucose control.

Timeline

Start
2008-02
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject EX1000 Unknown Subcutaneous
Comparator insulin NPH Protein / enzyme biologic Subcutaneous